Arcellx Inc — Quarterly Financial Statistics (NASDAQ:ACLX) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics

Quarterly Annual

Cash from operating activities -46.03 M-63.15 M-39.73 M-49.21 M-58.17 M -210.26 M Cash from investing activities -4.12 M37.78 M10.74 M-20.03 M57.8 M 86.3 M Cash from financing activities -6.02 M543 K10.26 M86.1 M1.63 M 98.53 M Free cash flow -47.53 M-63.92 M-40.22 M-49.5 M-58.94 M -212.59 M

뉴스

Gilead Strengthens Inflammation Portfolio With Ouro Medicines Deal

Top 2 Health Care Stocks That May Fall Off A Cliff This Month - Arcellx (NASDAQ:ACLX), Atea Pharmaceuticals (NASDAQ:AVIR)

Cantor Fitzgerald reiterates Gilead stock rating on Yeztugo sales

Will GILD's Move to Acquire ACLX Boost Its Cell Therapy Franchise?

제퍼리스, 파이프라인 리스크에 암젠 주식 ’보유’ 등급 개시

Jefferies initiates Amgen stock with hold rating on pipeline risk

길리어드 78억 달러 인수 앞둔 아셀렉스 실적 발표 예정

Arcellx set to report earnings amid $7.8B Gilead deal

BofA reiterates Gilead Sciences stock Buy rating on Yeztugo uptake

Fewer Deals, Bigger Stakes: Deciphering The 2026 M&A Landscape And The Rise Of Megadeals

Top 2 Health Care Stocks That May Crash This Quarter - Arcellx (NASDAQ:ACLX), Anika Therapeutics (NASDAQ:ANIK)

Arcellx Inc, 사상 최고치인 114.27 USD 기록